Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (131-140 of 258) with videos related to

Pageof 26
Sort By:
The Lancet. Oncology|May 10, 2025
Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health recordsHend Hassan, Isaac Allen, Tameera Rahman, et al.
Journal of Medical Genetics|November 30, 2021
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factorsAndrew Lee, Xin Yang, Jonathan Tyrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2007
Analysis of PALB2/FANCN-associated breast cancer familiesMarc Tischkowitz, Bing Xia, Nelly Sabbaghian, et al.
Journal of Medical Genetics|April 10, 2019
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA reportAmanda B Spurdle, Stephanie Greville-Heygate, Antonis C Antoniou, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline <i>ATM</i> sequence variantsMarcy E Richardson, Megan Holdren, Terra Brannan, et al.
Journal of Medical Genetics|October 21, 2024
Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based studyLucy Loong, Catherine Huntley, Joanna Pethick, et al.
Journal of Medical Genetics|September 26, 2022
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C</i>, <i>RAD51D</i>, <i>BARD1</i> updates to tumour pathology and cancer incidenceAndrew Lee, Nasim Mavaddat, Alex Cunningham, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2022
Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK)Lucy Loong, Alice Garrett, Sophie Allen, et al.
American Journal of Human Genetics|September 24, 2024
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variantsMarcy E Richardson, Megan Holdren, Terra Brannan, et al.
Genes|February 25, 2023
Molecular Genetic Characteristics of <i>FANCI</i>, a Proposed New Ovarian Cancer Predisposing GeneCaitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, et al.
Pageof 26

Showing results (131-140 of 258) with videos related to

Sort By:
Pageof 26
The Lancet. Oncology|May 10, 2025
Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health recordsHend Hassan, Isaac Allen, Tameera Rahman, et al.
Journal of Medical Genetics|November 30, 2021
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factorsAndrew Lee, Xin Yang, Jonathan Tyrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2007
Analysis of PALB2/FANCN-associated breast cancer familiesMarc Tischkowitz, Bing Xia, Nelly Sabbaghian, et al.
Journal of Medical Genetics|April 10, 2019
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA reportAmanda B Spurdle, Stephanie Greville-Heygate, Antonis C Antoniou, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline <i>ATM</i> sequence variantsMarcy E Richardson, Megan Holdren, Terra Brannan, et al.
Journal of Medical Genetics|October 21, 2024
Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based studyLucy Loong, Catherine Huntley, Joanna Pethick, et al.
Journal of Medical Genetics|September 26, 2022
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C</i>, <i>RAD51D</i>, <i>BARD1</i> updates to tumour pathology and cancer incidenceAndrew Lee, Nasim Mavaddat, Alex Cunningham, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2022
Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK)Lucy Loong, Alice Garrett, Sophie Allen, et al.
American Journal of Human Genetics|September 24, 2024
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variantsMarcy E Richardson, Megan Holdren, Terra Brannan, et al.
Genes|February 25, 2023
Molecular Genetic Characteristics of <i>FANCI</i>, a Proposed New Ovarian Cancer Predisposing GeneCaitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, et al.
Pageof 26